AI stumbles on medical ethics puzzles, echoing human cognitive shortcuts
Credit: Unsplash/CC0 Public Domain A study by investigators at the Icahn School of Medicine at Mount Sinai, in…
Early Alert: Infusion Pump Issue from Baxter
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has…
New brain scanner could speed up dementia diagnosis
A pioneering brain scanner, one of the first to be owned by an NHS trust in England, is…
Which Robotic Surgery Stock Is the Stronger Buy Today?
As robotic-assisted surgery continues its rising adoption in modern medicine, two industry leaders — Intuitive Surgical ISRG and…
AI Helps Prevent Medical Errors in Real-World Clinics
There has been a lot of talk about the potential for AI in health, but most of the…
Will The Healthcare Sector Be The Next Rotation?
Investors aware of which types of stocks are rotating in and out favor have a distinct advantage. On…
The shocking risk every smart student faces when applying to medical school
The threats we face throughout our medical practice years are rarely published in the world medical practice literature…
‘Is nursing still the career we were promised?’
From our first year as student nurses, we dream big. We picture ourselves wearing uniforms on wards where…
UnitedHealth: Why This Is the Time to Buy the Dip – FXEmpire
UnitedHealth: Why This Is the Time to Buy the Dip FXEmpireUnitedHealth Group (UNH) Sees a More Significant Dip Than…
Everlab raised $15 million to fight disease in ‘healthy’ people
Published on July 22, 2025 Melbourne startup Everlab is blending AI, full-body diagnostics and deep data to transform…
As IVF demand surges, Israel’s IMMA Health offers a scalable solution
Since the 1980s, IVF monitoring has relied on in-clinic transvaginal ultrasounds, multiple times per cycle, often at inconvenient…
Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
President Trump’s tariffs could erode healthcare companies’ profits, but some may perform well regardless. Eli Lilly and Novartis…